Orosomucoid 2 Polyclonal Antibody

Lane 1: Siha cell lysates probed with Orosomucoid 2 Polyclonal Antibody, Unconjugated (bs-9915R) at 1:1000 dilution and 4˚C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C.

Lane 1: Siha cell lysates probed with Orosomucoid 2 Polyclonal Antibody, Unconjugated (bs-9915R) at 1:1000 dilution and 4˚C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C.

Lane 1: Hela cell lysates probed with Orosomucoid 2 Polyclonal Antibody, Unconjugated (bs-9915R) at 1:1000 dilution and 4˚C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C.

Lane 1: Hela cell lysates probed with Orosomucoid 2 Polyclonal Antibody, Unconjugated (bs-9915R) at 1:1000 dilution and 4˚C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C.

Lane 1: Hela cell lysates probed with Orosomucoid 2 Polyclonal Antibody, Unconjugated (bs-9915R) at 1:1000 dilution and 4˚C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C.

Lane 1: Hela cell lysates probed with Orosomucoid 2 Polyclonal Antibody, Unconjugated (bs-9915R) at 1:1000 dilution and 4˚C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C.

Lane 1: HepG2 cell lysates probed with Orosomucoid 2 Polyclonal Antibody, Unconjugated (bs-9915R) at 1:1000 dilution and 4˚C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C.

Lane 1: HepG2 cell lysates probed with Orosomucoid 2 Polyclonal Antibody, Unconjugated (bs-9915R) at 1:1000 dilution and 4˚C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C.

Applications

WB
IHC-P
IF(IHC-P)

Reactivity

Human

Overview
Catalog #	bs-9915R
Product Name	Orosomucoid 2 Polyclonal Antibody
Applications	WB, IHC-P, IF(IHC-P)
Reactivity	Human
Specifications
Conjugation	Unconjugated
Host	Rabbit
Source	KLH conjugated synthetic peptide derived from human Orosomucoid 2
Immunogen Range	101-201/201
Clonality	Polyclonal
Isotype	IgG
Concentration	1ug/ul
Purification	Purified by Protein A.
Storage Buffer	0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Storage Condition	Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
Target
Gene ID	5005
Synonyms	Orosomucoid-2; AGP 2; AGP-2; AGP B; AGP-B; AGP2; Alpha 1 acid glycoprotein 2; Alpha 1 acid glycoprotein type 2; OMD 2; OMD2; OMD-2; ORM 2; ORM2; ORM-2; Orosomucoid2; A1AG2_HUMAN.
Background	Orosomucoid 2 is a key acute phase plasma protein. Because of its increase due to acute inflammation, this protein is classified as an acute-phase reactant. The specific function of this protein has not yet been determined; however Orosomucoid 2 appears to function in modulating the activity of the immune system during the acute-phase reaction.
Application Dilution
WB	1:300-5000
IHC-P	1:200-400
IF(IHC-P)	1:50-200

Powered by Bioz See more details on Bioz